Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( October )
A postcard from ... Slovakia
We take a look at how this young country is managing healthcare and controlling costs(more)
The Pharmafocus Interview: Jan Lundberg
AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence
Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
PharmafocusNews Register for New Alert
News for January 2004
Previous Months: September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Pfizer takes giant step forward
Industry leader maintains dominance..(more)

 Commission restates its support for parallel trade
New guidelines set out..(more)

 Pfizer to sell diagnostics business
Pfizer sells non-core business..(more)

 Abbott raises sales expectations for Humira
Company's 2003 sales steady..(more)

 Aventis and Sanofi attempt to quash merger rumours
Major shareholder may divest..(more)

 Genzyme to set up research facility in UK
Coup for UK and Cambridge..(more)

 W.A.R marshals forces for healthcare push
Agency sees expansion potential..(more)

 Pfizer to sell-off sixty OTC products in Europe
Giant to sell off Pharmacia subsidiaries..(more)

 Eloxatin approved in US as first line treatment
FDA gives drug priority review..(more)

 GSK faces $5 billion tax claim
Other companies could follow..(more)

 Renal care standards unveiled
First NSF documents published..(more)

 More states defy FDA warnings on re-imports
Virgina and New Hampshire to take action..(more)

 Landmark parallel trade victory for industry
Trade body vows to fight on..(more)

 New patient forums launch recruitment drive
Public to be put at centre of health..(more)

 NHS to sue generic firms over price-fixing
NHS seeks £30 million compensation..(more)

 Licensing delays cost SkyePharma
SkyePharma reports loss for 2003..(more)

 Prescribing indicators included in PCT ratings overhaul
NHS Alliance unhappy with changes..(more)

 Exanta ready for launch across Europe
Exanta approved in France..(more)

 New GP contract ready for local negotiation
GMS contract set for 1 April..(more)

 Elan sells European sales and marketing business for $120 million
Elan continues recovery strategy..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.